Allogene Therapeutics, Inc. (ALLO) vs Prime Medicine, Inc. (PRME)
Allogene Therapeutics, Inc. and Prime Medicine, Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and Prime Medicine, Inc. are of similar size ($609.4M and $594.2M). Allogene Therapeutics, Inc. grew revenue faster over the last twelve months: 7,613.1% against −17.9%. Allogene Therapeutics, Inc. has the higher net margin (−3,517.4% vs −4,613.1%) and the lower return on invested capital (−108.8% vs 0.00%). Across the 15 metrics below, Allogene Therapeutics, Inc. leads on 12 and Prime Medicine, Inc. on 3.
Valuation
Profitability
| Metric | ALLO | PRME | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (3,832.45%) | (4,824.94%) | 0.00% |
| Net margin | (3,517.41%) | (4,613.11%) | 0.00% |
| Free cash flow margin | (2,180.62%) | (3,850.92%) | 0.00% |
| Return on equity | (42.39%) | (373.29%) | (57.72%) |
| Return on assets | (32.43%) | (71.16%) | (49.22%) |
| Return on invested capital | (108.81%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack